Cowen & Co. Downgrades Aurora Cannabis to Market Perform, Lowers Price Target to $2.5

Cowen & Co. analyst Vivien Azer downgrades Aurora Cannabis (TSX:ACB) from Outperform to Market Perform and lowers the price target from $6 to $2.5.